Aerie Pharmaceuticals, Inc.

NasdaqGM:AERI Stock Report

Market Cap: US$753.6m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Aerie Pharmaceuticals Management

Management criteria checks 2/4

Key information

Raj Kannan

Chief executive officer

US$4.3m

Total compensation

CEO salary percentage0.6%
CEO tenureless than a year
CEO ownership0.4%
Management average tenureless than a year
Board average tenure7.4yrs

Recent management updates

Recent updates

Alcon to acquire Aerie Pharmaceuticals at ~$770M, enhancing its ophthalmic pharmaceutical portfolio

Aug 23

Aerie Pharmaceuticals grants 16.9K stock options

Aug 15

Aerie Pharma rises 14% after Q2 result beat on higher glaucoma franchise sales

Aug 05

Aerie Pharma completes enrollment in first Phase 3 trial of netarsudil in Japan

Jun 17

Aerie Pharmaceuticals, Inc.'s (NASDAQ:AERI) Path To Profitability

Feb 27
Aerie Pharmaceuticals, Inc.'s (NASDAQ:AERI) Path To Profitability

Who Has Been Selling Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Shares?

Jan 28
Who Has Been Selling Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Shares?

Aerie Pharmaceuticals receives European approval for Roclanda

Jan 11

Aerie Pharmaceuticals (NASDAQ:AERI) Share Prices Have Dropped 76% In The Last Three Years

Dec 24
Aerie Pharmaceuticals (NASDAQ:AERI) Share Prices Have Dropped 76% In The Last Three Years

Is Aerie Pharmaceuticals (NASDAQ:AERI) A Risky Investment?

Nov 28
Is Aerie Pharmaceuticals (NASDAQ:AERI) A Risky Investment?

European advisory group backs Aerie Pharma's Roclanda

Nov 13

CEO Compensation Analysis

How has Raj Kannan's remuneration changed compared to Aerie Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-US$37m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$69m

Dec 31 2021US$4mUS$24k

-US$75m

Compensation vs Market: Raj's total compensation ($USD4.25M) is about average for companies of similar size in the US market ($USD3.95M).

Compensation vs Earnings: Insufficient data to compare Raj's compensation with company performance.


CEO

Raj Kannan (58 yo)

less than a year

Tenure

US$4,253,490

Compensation

Mr. Raj Kannan serves as Chief Executive Officer and Director at Aerie Pharmaceuticals, Inc since December 20, 2021 and serves as its Principal Financial Officer since March 1, 2022. He has been Chief Exec...


Leadership Team

NamePositionTenureCompensationOwnership
Raj Kannan
CEO, Principal Financial Officer & Directorless than a yearUS$4.25m0.44%
$ 3.3m
Casey Kopczynski
Co-Founder17.8yrsUS$1.46m0.57%
$ 4.3m
John LaRocca
General Counsel & Secretary4.8yrsUS$1.45m0.11%
$ 817.1k
Peter Lang
Chief Financial Officerless than a yearno data0.18%
$ 1.4m
Michelle Senchyna
Head of Clinical Development & Operationsno datano datano data
Jeffrey Calabrese
VP of Finance & Principal Accounting Officer3.4yrsno data0.038%
$ 283.4k
Carolyn McAuliffe
Senior Director of Communications1.2yrsno datano data
Wanda Francies
Head of Human Resourcesless than a yearno datano data
Marvin Garrett
Head of Regulatory Affairs & Quality Assuranceless than a yearno datano data
Craig Skenes
Head of Business Developmentless than a yearno datano data
Kenneth Ruettimann
Head of Manufacturingless than a yearno datano data
Gary Sternberg
Chief Medical Officerless than a yearno datano data

0.8yrs

Average Tenure

57.5yo

Average Age

Experienced Management: AERI's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Raj Kannan
CEO, Principal Financial Officer & Directorless than a yearUS$4.25m0.44%
$ 3.3m
Benjamin McGraw
Independent Chairman8.2yrsUS$1.77m0.085%
$ 640.3k
David Gryska
Independent Director4.2yrsUS$168.67k0.027%
$ 205.7k
Mechiel M. Toit
Independent Director7.4yrsUS$163.67k0.033%
$ 245.5k
Peter McDonnell
Independent Director2.4yrsUS$161.17k0.016%
$ 121.9k
Richard Croarkin
Independent Director7.5yrsUS$169.05k0.033%
$ 245.5k
Julie McHugh
Independent Director7.4yrsUS$173.67k0.033%
$ 245.5k

7.4yrs

Average Tenure

67yo

Average Age

Experienced Board: AERI's board of directors are considered experienced (7.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.